Skip to main content
Top
Published in: Obesity Surgery 5/2021

01-05-2021 | Obesity | Letter to the Editor

Gastric Bypass in an Adolescent with Obesity, Insulin Resistance, and Type 1 Diabetes

Authors: Margaret A. Stefater, Brynn E. Marks

Published in: Obesity Surgery | Issue 5/2021

Login to get access

Excerpt

Whereas type 2 diabetes (T2D) is characterized by insulin resistance, type 1 diabetes (T1D) is defined by autoimmune-mediated β cell destruction resulting in insulin deficiency. Acknowledgement that asymptomatic β cell autoimmunity precedes clinical presentation has led to recognition of stages of T1D. Stage 1 is defined by islet cell autoimmunity with normoglycemia. In Stage 2, patients progress to asymptomatic dysglycemia, followed by symptomatic hyperglycemia in Stage 3 [1]. In addition to β cell autoimmunity, patients with T1D and obesity have insulin resistance [2]. Bariatric surgery (BS) is increasingly accepted as the most effective treatment for T2D and can reduce insulin requirements in patients with T1D [3]. …
Literature
Metadata
Title
Gastric Bypass in an Adolescent with Obesity, Insulin Resistance, and Type 1 Diabetes
Authors
Margaret A. Stefater
Brynn E. Marks
Publication date
01-05-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 5/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-05190-z

Other articles of this Issue 5/2021

Obesity Surgery 5/2021 Go to the issue